Literature DB >> 29579523

Impact of the I2AO2 interdisciplinary program led by nursing on psychological comorbidity and quality of life: Randomized controlled clinical trial.

Virginia Esperanza Fernández-Ruiz1, José Antonio Paniagua-Urbano2, María Solé-Agustí2, Alfonso Ruiz-Sánchez2, José Gómez-Marín2, David Armero-Barranco3.   

Abstract

OBJECTIVE: Obesity is an entity of highly prevalent multifactorial origin with associated metabolic and psychological comorbidity, causing a negative impact on the quality of life of those who suffer from it. The objective is to evaluate the impact of an interdisciplinary program for nurse-led obesity on quality of life related to health and anxiety.
METHODS: Randomized controlled clinical trial with a sample of 74 subjects diagnosed with obesity (EG: n=37; CG: n=37). The intervention consisted of a 12-month interdisciplinary program (with pre-test, 12month and 24month follow-up) coordinated by nurses.
RESULTS: The anxiety analysis shows that there is no effect of the intervention on S-STAI (F2; 144=0.246; p=0.782), which has increased in both groups. However, there is an effect on T-STAI (F2; 144=8872; p<0.001), which only increases in the control group. The interdisciplinary program has significantly improved health-related quality of life (SF-36), both in physical health parameters as well as in mental health.
CONCLUSION: The interdisciplinary program led by nursing professionals has improved the quality of life related to health and has prevented the increase of anxiety-trait in participants, maintaining the long-term effects.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Health-related quality of life; Multi-professional practice; Nursing; Obesity

Mesh:

Year:  2017        PMID: 29579523     DOI: 10.1016/j.apnu.2017.11.014

Source DB:  PubMed          Journal:  Arch Psychiatr Nurs        ISSN: 0883-9417            Impact factor:   2.218


  1 in total

1.  Effectiveness of the I2AO2 interdisciplinary programme led by nurses on metabolic syndrome and cardiovascular risk: a randomized, controlled trial.

Authors:  V E Fernández-Ruiz; J A Paniagua-Urbano; M Solé-Agustí; A Ruiz-Sánchez; J Gómez-Marín; D Armero-Barranco
Journal:  J Int Med Res       Date:  2018-03-27       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.